Clinical trials: Diabetic Wounds

Hard to Heal Wounds

Safety and Efficacy Study of HO/03/03 10-40 Micro Grams to Treat Hard to Heal Wounds

• Unknown status
• Age: 18 to 90 years
• Early Phase 1

This multicenter, prospective, open-label, outpatient study will assess the safety and efficacy of HO/03/03 10µg applied topically once daily for up to 24 weeks in up to 100 subjects with Hard to Heal documented chronic wounds of…

Trial name

H2H (NCT01772303)

Testing

HO/03/03 10-40 µg

Where

Israel

Volunteers

100 people

Sponsor

HealOr